Rodrigo López-Muñoz

6PUBLICATIONS
13CO-AUTHORS
Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 20, 2026
The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRASG12C mutation.

Antonia Martin-Martin, Carina Chipón, Constanza Guzman-Kunstmann

|Nov 09, 2024
Impact of Nordihydroguaiaretic Acid on Proliferation, Energy Metabolism, and Chemosensitization in Non-Small-Cell Lung Cancer (NSCLC) Cell Lines.

Carina Chipón, Paula Riffo, Loreto Ojeda

|Oct 25, 2024
Dual-Action Gemcitabine Delivery: Chitosan-Magnetite-Zeolite Capsules for Targeted Cancer Therapy and Antibacterial Defense.

Yuly Andrea Guarín-González, Gerardo Cabello-Guzmán, José Reyes-Gasga

|Jun 10, 2023
Mind the Curve: Dose-Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies.

Olga Fuentealba-Manosalva, Matías Mansilla, Neudo Buelvas

|May 22, 2019
Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer.

Antonia Martin-Martin, Andrés Rivera-Dictter, Matías Muñoz-Uribe

Pageof 1